Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab

Background/aimsTo evaluate the effect of adjuvant intravitreal triamcinolone acetonide (ITA) for radiation maculopathy (RM) recalcitrant to high-dose bevacizumab in patients with choroidal melanoma after plaque radiotherapy.MethodsEight eyes of eight patients with RM secondary to plaque radiotherapy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of ophthalmology 2017-12, Vol.101 (12), p.1694-1698
Hauptverfasser:	Kaplan, Richard I, Chaugule, Sonal S, Finger, Paul T
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Bevacizumab - administration & dosage Brachytherapy - adverse effects Charged particles Choroid Neoplasms - radiotherapy Clinical Science Diabetes Diabetic retinopathy Dose-Response Relationship, Drug Edema Female Fluorescein Angiography Follow-Up Studies Fundus Oculi Glucocorticoids - administration & dosage Humans Immunotherapy Intravitreal Injections Iodine Macula Lutea - pathology Macula Lutea - radiation effects Male Melanoma Melanoma - radiotherapy Middle Aged Monoclonal antibodies Ophthalmology Patients Radiation Injuries - complications Radiation Injuries - drug therapy Radiation therapy Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors Retinal Diseases - diagnosis Retinal Diseases - drug therapy Retinal Diseases - etiology Retrospective Studies Success Systematic review Systemic diseases Targeted cancer therapy Time Factors Tomography, Optical Coherence Triamcinolone Acetonide - administration & dosage Vascular endothelial growth factor Visual Acuity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!